What the joint-preservation window actually means

'My surgeon has mentioned both repair options and a partial replacement — how do I know which one applies to me?' That question arrives at a specific moment in the progression of knee damage, and it has a name: the joint-preservation window.

The window describes the period when the knee is damaged enough to warrant active intervention but not so far gone that biological repair has become futile. At one end, minor surface damage may still respond to conservative measures — physiotherapy, load management, or injection support. At the other, widespread bone-on-bone disease across an entire compartment has moved beyond the reach of repair and into the territory of mechanical resurfacing. Most patients asking this question sit somewhere between those two points, typically between their mid-twenties and mid-fifties, with focal or early-compartmental disease rather than end-stage arthritis.

The window is time-sensitive in both directions. Moving to a partial replacement too early means sacrificing biological tissue that could have been restored; waiting too long after repair options have been exhausted risks a worse starting point for any subsequent procedure.

Rather than a binary choice, the pathway is a spectrum: conservative care, then biologic or injection support, then cartilage restoration, then alignment surgery or partial replacement, and finally total knee replacement if all else fails. The sections that follow map each stage of that spectrum and identify the factors that move a patient along it.

Why knee cartilage almost never heals on its own

The core problem with knee cartilage is structural: it has no blood supply. Nutrients reach the articular surface through synovial fluid rather than through vessels, which means chondrocytes — the cells responsible for maintaining cartilage — cannot mount the kind of inflammatory repair response that heals a broken bone or a muscle tear. Once the surface is damaged, the body produces little of value to replace it.

Defect size matters considerably. Lesions above roughly one centimetre in diameter are substantially more likely to enlarge and progress towards osteoarthritis than smaller injuries, making size one of the clearest practical markers clinicians use when weighing the urgency of intervention.

Long-term follow-up data underline what happens when that urgency is ignored. Sanders et al. (Am J Sports Med, 2017) found markedly higher rates of osteoarthritis at a mean 16-year follow-up in patients whose cartilage fragments were simply removed compared with those who underwent surgical restoration — a finding that directly supports the case for acting within the window rather than taking a 'wait and see' approach.

Any repair tissue the body does produce spontaneously is fibrocartilage — a scar-like material that is mechanically weaker than native hyaline cartilage and tends to break down under sustained load. Concurrent problems such as malalignment, meniscal loss, or ligament instability make matters worse by concentrating force on cartilage that is already vulnerable, accelerating wear well beyond what the primary defect alone would cause.

Which repair options exist and who they suit

Choosing a repair technique turns primarily on defect size, the patient's biological capacity to heal, and the state of the surrounding joint. Presenting them in ascending complexity makes the logic of the progression clear.

Smaller defects (up to approximately 3 cm²)

For focal cartilage damage within this range, a ChondroFiller injection — an ultrasound-guided outpatient procedure that places an injectable collagen scaffold into the defect under image guidance — offers a minimally invasive option. The scaffold supports matrix-induced chondrogenesis, recruiting the patient's own progenitor cells without theatre admission or a surgical incision.

Microfracture was historically the standard surgical starting point for small lesions, but its role has sharply declined. Evidence shows the fibrocartilage it generates begins to break down within roughly two to three years under load, and repeated perforations can damage the subchondral bone plate, compromising the structural foundation on which any future repair must sit.

AMIC (autologous matrix-induced chondrogenesis) modifies microfracture by layering a collagen scaffold over the marrow channels in a single procedure, reducing some of the subchondral risk — a bridging option between simple marrow stimulation and full cell-based repair.

Medium defects (1–4 cm²)

OATS or mosaicplasty transfers osteochondral plugs harvested from a lower-load region of the patient's own knee into the defect, delivering genuine hyaline cartilage in one operation. Single plugs suit lesions of roughly 1–2 cm²; mosaic configurations can address up to approximately 4 cm². Donor-site morbidity — localised discomfort and occasional surface irregularity at the harvest site — is a real and acknowledged consideration.

Larger defects (2–10 cm²): cell-based repair

MACI seeds cultured chondrocytes onto a Type I/III collagen membrane, addressing several technical drawbacks of first-generation ACI. Five-year randomised trial evidence supports its use for defects in the 2–10 cm² range in biologically capable patients. Both MACI and ACI are two-stage procedures with significant rehabilitation demands — a practical factor in patient selection.

Very large or post-traumatic defects

Where a defect exceeds what autograft can safely cover, fresh osteochondral allograft (OCA) supplies matched donor cartilage and subchondral bone. Gross et al. (Clin Orthop Relat Res, 2008) reported positive long-term follow-up outcomes in post-traumatic cases, supporting its role as the upper end of the repair spectrum.

Adjuncts: alignment and biologics

When malalignment is concentrating load on a repaired surface, HTO or DFO osteotomy may accompany the cartilage procedure to redistribute force — acting as a mechanical safeguard rather than a repair in its own right. Biologic injections such as PRP or BMAC may support the healing environment but serve a similarly supporting, not primary, role.

Every option above depends on the defect remaining focal and the surrounding joint remaining structurally intact. Once that condition no longer holds, the decision shifts entirely.

Signs the repair window is closing

Several clinical features, when present, indicate that biological repair is no longer the right primary strategy. These thresholds are largely consensus-based rather than defined by head-to-head randomised trials — an honest gap worth naming — but they are well-supported across clinical guidelines and represent the factors a consultant would weigh systematically.

Diffuse or multi-lesion disease. Cartilage repair techniques — whether scaffold-based, cell-based, or graft-based — work by restoring a contained focal surface. When damage is spread across a whole compartment, or several distinct lesions are present, there is no longer a bounded area to restore; the entire articular substrate has degraded.

Bone-on-bone involvement. Once subchondral bone is exposed within the compartment, biological scaffolds and grafts lack a viable cartilage bed to integrate with. The mechanical and biological prerequisites for repair are absent.

Prior cartilage repair failure, especially after microfracture. Repeated subchondral perforations can damage the bone plate that cell-based repair depends on. A failed marrow-stimulation procedure meaningfully reduces the likelihood that a subsequent MACI or ACI will succeed, because the structural foundation has already been compromised.

Significant malalignment that osteotomy cannot adequately correct. Varus or valgus deformity concentrates load unevenly across the joint; where realignment surgery alone cannot sufficiently redistribute that force, biological repair in the overloaded compartment is unlikely to hold.

Loss of meniscal support in the affected compartment. The meniscus distributes load across the tibial plateau; its absence focuses force directly onto already-compromised cartilage, removing the protective mechanical environment that any repair tissue needs to survive.

Recognising these signals early matters precisely because crossing them does not mean all options are exhausted — partial replacement remains a more conservative intervention than total arthroplasty, and the distinction is clinically significant.

Partial knee replacement as the last preservation step

Partial knee replacement — unicompartmental knee arthroplasty, or UKA — occupies a specific and often misunderstood place on the spectrum. It is not giving up on preservation; it is using mechanical resurfacing to protect what remains.

The procedure replaces only the diseased compartment, most commonly the medial side, while retaining the cruciate ligaments, bone stock, and the healthy compartments of the joint. That distinction matters practically: recovery after UKA is faster and rehabilitation more straightforward than after total knee replacement, because less tissue is disturbed and the natural mechanics of the remainder of the knee are largely maintained.

Eligibility criteria are precise. Single-compartment disease, intact anterior and posterior cruciate ligaments, a deformity that is either neutral or correctable, and failure of non-operative management are the standard requirements. These criteria directly contrast with the cartilage-repair population described in earlier sections: a patient with multi-compartment involvement, absent cruciate ligaments, or a fixed uncorrectable deformity is not a UKA candidate. Extending indications beyond this framework is associated with markedly higher revision rates — patient selection is where UKA survivorship is won or lost.

If disease subsequently progresses and total replacement becomes necessary, the preserved bone stock from a prior UKA makes that conversion more straightforward than managing a failed primary total knee replacement. The transition, if it comes, is more predictable.

For patients in the 40–60 age bracket, where the choice between repair and partial replacement carries the greatest long-term consequence, the consultation itself is the critical analytical moment. The questions worth raising explicitly with a surgeon are: what happens to this compartment if cartilage repair is attempted and fails, and does UKA remain a realistic next step if subchondral bone is preserved throughout?

Getting assessed at the right time

The right moment to seek specialist review is when symptoms persist beyond a reasonable trial of conservative care — not after a compartment has collapsed and fewer options remain. Waiting for pain to become severe, or for a plain X-ray to confirm bone-on-bone change, often means the repair window has already narrowed substantially.

A thorough assessment goes beyond plain imaging. MRI is the standard for characterising cartilage damage; AI-assisted analysis — including cartilage and meniscus segmentation with T2 mapping, as offered through onMRI™ at the Sleaford clinic — can identify defect size, depth, and subchondral bone involvement well before structural loss is visible on X-ray. Where malalignment or uneven load distribution is suspected, objective gait analysis such as MAI Motion® adds biomechanical context that directly affects which intervention is appropriate and whether alignment correction should accompany it. Clinical grading, advanced MRI, and — where indicated — a biomechanical profile together allow a consultant to place a patient accurately on the repair-to-replacement spectrum.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without referral. Book an assessment at lincolnshireknee.co.uk.

1. [1] Cartilage. https://en.wikipedia.org/?curid=166945 https://en.wikipedia.org/?curid=166945
2. [2] Articular cartilage damage. https://en.wikipedia.org/?curid=19057920 https://en.wikipedia.org/?curid=19057920
3. [3] Articular cartilage repair. https://en.wikipedia.org/?curid=19042351 https://en.wikipedia.org/?curid=19042351
4. [4] Unicompartmental knee arthroplasty. https://en.wikipedia.org/?curid=16991704 https://en.wikipedia.org/?curid=16991704
5. [5] Knee replacement. https://en.wikipedia.org/?curid=2830398 https://en.wikipedia.org/?curid=2830398